Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout

QJM: An International Journal of Medicine

Volumn 106, Issue 8, 2013, Pages 721-729

  Krishnan, E ^a   Akhras, K S ^b   Sharma, H ^c   Marynchenko, M ^c   Wu, E Q ^c   Tawk, R ^b   Liu, J ^d   Shi, L ^d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Takeda Pharmaceuticals International Inc   (United States)

^c ANALYSIS GROUP   (United States)

^d TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; URIC ACID;

ADULT; ARTICLE; BODY MASS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; GOUT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERURICEMIA; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; UNITED STATES; URIC ACID BLOOD LEVEL; VETERAN;

AGED; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; GOUT; HUMANS; HYPERURICEMIA; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES; URIC ACID; VETERANS;

EID: 84880739574     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hct093     Document Type: Article

References (34)

1. Doherty M. New insights into the epidemiology of gout. Rheumatology (Oxford) 2009; 48(Suppl. 2):ii2-8.
2. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyper-uricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011; 63:3136-41.
3. Pillinger MH, Goldfarb DS, Keenan RT. Gout and its comor-bidities. Bull NYU Hosp Jt Dis 2010; 68:199-203.
4. Choi HK, De Vera MA, Krishnan E. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology 2008; 47:1567-70.
5. Primatesta P, Plana E, Rothenbacher D. Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population. BMC Musculoskelet Disord 2011; 12:103.
6. Charles BA, Shriner D, Doumatey A, Chen G, Zhou J, Huang H, et al. A genome-wide association study of serum uric acid in African Americans. BMC Med Genomics 2011; 4:17.
7. Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN. Uric acid and the development of metabolic syndrome in women and men. Metabolism 2008; 57:845-52.
8. So A, Thorens B. Uric acid transport and disease. J Clin Invest 2010; 120:1791-9.
9. Bhole V, Choi JW, Kim SW, de Vera M, Choi H. Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am J Med 2010; 123:957-61.
10. Chien KL, Chen MF, Hsu HC, Chang WT, Su TC, Lee YT, et al. Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem 2008; 54:310-6.
11. Dehghan A, van Hoek M, Sijbrands EJ, Hofman A, Witteman JC. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008; 31:361-2.
12. Kramer CK, von Muhlen D, Jassal SK, Barrett-Connor E. Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study. Diabetes Care 2009; 32:1272-3.
13. Krishnan E, Pandya BJ, Chung L, Hariri A, Dabbous O. Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemiol 2012; 176:108-16.
14. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K. Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers. Eur J Epidemiol 2003; 18:523-30.
15. Niskanen L, Laaksonen DE, Lindstrom J, Eriksson JG, Keinanen-Kiukaanniemi S, Ilanne-Parikka P, et al. Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance: the Finnish Diabetes Prevention Study. Diabetes Care 2006; 29:709-11.
16. Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K. Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: The Osaka Health Survey. J Hypertens 2001; 19:1209-15.
17. Lin KC, Tsai ST, Lin HY, Chou P. Different progressions of hyperglycemia and diabetes among hyperuricemic men and women in the kinmen study. J Rheumatol 2004; 31:1159-65.
18. Nan H, Qiao Q, Soderberg S, Pitkaniemi J, Zimmet P, Shaw J, et al. Serum uric acid and incident diabetes in Mauritian Indian and Creole populations. Diabetes Res Clin Pract 2008; 80:321-7.
19. Kim SY, England L, Sappenfield W, Wilson HG, Bish CL, Salihu HM, et al. Racial/ethnic differences in the percentage of gestational diabetes mellitus cases attributable to overweight and obesity, Florida, 2004-2007. Prev Chronic Dis 2012; 9:E88.
20. Kim SY, England L, Wilson HG, Bish C, Satten GA, Dietz P. Percentage of gestational diabetes mellitus attributable to overweight and obesity. Am J Public Health 2010; 100:1047-52.
21. Morimoto A, Ohno Y, Tatsumi Y, Nishigaki Y, Maejima F, Mizuno S, et al. Risk of smoking and body mass index for incidence of diabetes mellitus in a rural Japanese population. Prev Med 2012; 54:341-4.
22. Pirkola J, Pouta A, Bloigu A, Miettola S, Hartikainen AL, Jarvelin MR, et al. Prepregnancy overweight and gestational diabetes as determinants of subsequent diabetes and hypertension after 20-year follow-up. J Clin Endocrinol Metab 2010; 95:772-8.
23. Jiang Y, Chen Y, Mao Y. The contribution of excess weight to prevalent diabetes in Canadian adults. Public Health 2008; 122:271-6.
24. Verdecchia P, Reboldi G, Angeli F, Borgioni C, Gattobigio R, Filippucci L, et al. Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension 2004; 43:963-9.
25. Heinig M, Johnson RJ. Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med 2006; 73:1059-64.
26. Sonoda H, Takase H, Dohi Y, Kimura G. Uric acid levels predict future development of chronic kidney disease. Am J Nephrol 2011; 33:352-7.
27. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004; 44:642-50.
28. Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 2008; 19:2407-13.
29. Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, Totsuka K, et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care 2009; 32:1737-42.
30. Wang T, Bi Y, Xu M, Huang Y, Xu Y, Li X, et al. Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese. Endocrine 2011; 40:109-16.
31. Lin DY, Wei LJ. The robust inference for the proportional hazards model. J Am Stat Assoc 1989; 84:1074-8.
32. Eide GE, Gefeller O. Sequential and average attributable fractions as aids in the selection of preventive strategies. J Clin Epidemiol 1995; 48:645-55.
33. Ruckinger S, von Kries R, Toschke AM. An illustration of and programs estimating attributable fractions in large scale surveys considering multiple risk factors. BMC Med Res Methodol 2009; 9:7.
34. Viazzi F, Leoncini G, Vercelli M, Deferrari G, Pontremoli R. Serum uric acid levels predict new-onset type 2 diabetes in hospitalized patients with primary hypertension: the MAGIC study. Diabetes Care 2011; 34:126-8.